Extended Data Fig. 5: Neutralization of the SARS-CoV-2 variants D614G, Alpha, Beta and Delta by monoclonal antibodies that target the RBD and the NTD domains.
From: Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Neutralization curves of monoclonal antibodies. Dose–response analysis of the neutralization by four anti-RBD and four anti-NTD antibodies on the D614G strain (grey) and the Alpha (dark blue), Beta (light blue) and Delta (orange) variants. Data are mean ± s.d. of three independent experiments.
